Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vivitrol for Opioid-Dependent Offenders (IPOD)
NCT02110264Phase 3Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jun 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone in opioid use disorder (OUD), sponsored by University of California, Los Angeles. Started Jun 2015; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02110264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02110264.